N-aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
申请人:Luecking Ulrich
公开号:US20060229325A1
公开(公告)日:2006-10-12
This invention relates to pyrimidine derivatives of general formula (I)
in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, as inhibitors of cyclin-dependent kinases and VEGF-receptor tyrosine kinases, their production as well as their use as medications for treatment of various diseases.
本发明涉及通式(I)的嘧啶衍生物,其中Q,R1,R2,R3,R4,R5,X和m的含义如描述中所含,作为细胞周期蛋白依赖性激酶和VEGF受体酪氨酸激酶的抑制剂,它们的生产以及它们作为治疗各种疾病的药物的用途。